HUMAN insulin (HI) and porcine insulin (PI) are molecules which differ only by one amino acid residue. Both are used in the therapy of diabetes mellitus. The two types of insulin seem to differ in displacing antibodies from the insulin receptor site 1 and in interacting with the pharmacokinetics of lorazepam. 2 Moreover, there is evidence that cognitive brain functions may be differently affected by HI and PI under hypoglycemic conditions. Teuscher and associates 3-6 and others 7, 8 observed that the risk of hypoglycemia unawareness is increased in patients treated with HI compared to those treated with beef/pork insulin because of decreased neuroendocrine symptoms. Based on a postmortem analysis of unexplained deaths in IDDM, it has been suggested that treatment with HI may coincide with an increased risk of sudden deaths in sleep. 9 However, other groups did not confirm that the two types of insulin differ in terms of the frequency of hypoglycemia unawareness. [10] [11] [12] Using a neurophysiological approach to investigate possible differences in the effects of PI and HI on brain functions, Kern et al 13, 14 performed sensory evoked potential studies. When hypoglycemia was induced in healthy subjects by either PI or HI, the amplitude and latency of visual and auditory evoked potentials exhibited differences. These were observed 20 minutes after insulin administration and some of them also 50 minutes after insulin administration, when hypoglycemia had reached a steady state. The authors discuss the possibility that PI may be more rapidly transferred across the blood-brain barrier than HI. Although these studies may be relevant for assessing sensory aspects of brain functions in the course of a hypoglycemic episode, they do not address the question of whether functional differences between PI and HI exist under near-normoglycemic conditions. The only evidence for such a difference was reported by Flanigan et al 15 in an SLEEP, Vol. 21, No. 1, 1998 Summary: To investigate whether porcine insulin (PI) and human insulin (HI) have different effects on brain functions outside of hypoglycemia, sleep and the sleep EEG were recorded in eight insulin-dependent diabetes mellitus (IDDM) patients in three separate sessions of 2 consecutive nights. Near-normoglycemia was confirmed by measurements of capillary blood glucose before and after sleep and at 0145 hours. The treatment effect (PI compared to HI) consisted of a change in the NREM sleep EEG in the spindle frequency range. Spectral power density in the 14-Hz bin was reduced upon transfer from PI (session 1) to HI (session 2) in all subjects, and increased upon reversal to PI (session 3) in all but one subject. There were no significant treatment effects on any other sleep EEG variable or on sleep stages. The subjects rated their sleep as more sound and their state in the morning as more relaxed during PI treatment. They were, however, not blinded to the type of insulin they were using. Porcine insulin and human insulin may exert differential effects on spindle-generating mechanisms in the thalamocortical system. The results indicate that human insulin may affect brain functions differently compared to animal insulin under near-normoglycemic conditions. Key words: Power spectra; sleep; insulin-dependent diabetes mellitus; human insulin; porcine insulin.
HUMAN insulin (HI) and porcine insulin (PI) are molecules which differ only by one amino acid residue. Both are used in the therapy of diabetes mellitus. The two types of insulin seem to differ in displacing antibodies from the insulin receptor site 1 and in interacting with the pharmacokinetics of lorazepam. 2 Moreover, there is evidence that cognitive brain functions may be differently affected by HI and PI under hypoglycemic conditions. Teuscher and associates [3] [4] [5] [6] and others 7, 8 observed that the risk of hypoglycemia unawareness is increased in patients treated with HI compared to those treated with beef/pork insulin because of decreased neuroendocrine symptoms. Based on a postmortem analysis of unexplained deaths in IDDM, it has been suggested that treatment with HI may coincide with an increased risk of sudden deaths in sleep. 9 However, other groups did not confirm that the two types of insulin differ in terms of the frequency of hypoglycemia unawareness. [10] [11] [12] Using a neurophysiological approach to investigate possible differences in the effects of PI and HI on brain functions, Kern et al 13, 14 performed sensory evoked potential studies. When hypoglycemia was induced in healthy subjects by either PI or HI, the amplitude and latency of visual and auditory evoked potentials exhibited differences. These were observed 20 minutes after insulin administration and some of them also 50 minutes after insulin administration, when hypoglycemia had reached a steady state. The authors discuss the possibility that PI may be more rapidly transferred across the blood-brain barrier than HI. Although these studies may be relevant for assessing sensory aspects of brain functions in the course of a hypoglycemic episode, they do not address the question of whether functional differences between PI and HI exist under near-normoglycemic conditions. The only evidence for such a difference was reported by Flanigan et al 15 in an abstract. These authors observed differences in the sleep EEG and a shorter latency to stage 1 in IDDM patients treated with HI compared to those treated with PI. Many studies with animals showed effects of insulin on sleep architecture (for an overview see 16) . Since the different types of insulin were not compared, however, these studies are not further discussed.
The aim of the present study was to compare sleep and the sleep EEG of IDDM patients who were treated in succession with PI and HI. Subjects were initially observed on PI after long-time treatment, then were changed to HI, and finally, for a third session, were transferred back to PI. This third session was intended to reveal more precisely the treatment-related changes and to minimize the influence of confounding variables due to order effects and the knowledge of the treatment condition. The study was based on a quantitative analysis of the sleep EEG, a method that has been shown to be a very sensitive indicator of pharmacological influences on the brain. The sensitivity of the method has been demonstrated by previous experiments using a bedtime administration of a hypnotic dose of various benzodiazepines. These studies showed that distinct changes in the EEG spectra were still present in the following drug-free night. 17 Similarly, a moderate dose of ethanol (0.60 g/kg body weight) altered the sleep EEG on two nights, 18 and 200 mg caffeine administered in the morning had a significant effect on the sleep EEG in the subsequent night. 19 The question in the present study was whether the two types of insulin exert a differential effect on the sleep EEG.
SUBJECTS AND METHODS

Subjects
Eight subjects, four females and four males, with longstanding IDDM but no long-term vascular or neurological complications, participated in the study (Table 1 ). All subjects were transferred from PI to HI in 1986-88. Because of episodes of severe HI hypoglycemia unawareness, they had previously refused further treatment with HI, but they agreed to participate in the study in view of their personal interest in possible differences between the two types of insulin. Written informed consent was obtained and the study protocol was approved by the local ethical committee for research on human subjects. Medical history, current health status and sleep-wake habits were assessed by questionnaire. Five subjects reported a good sleep quality and three reported a medium sleep quality on a three-point scale (good, medium, poor). Habitual nocturnal sleep duration was 6.9±1.2 hours ([SEM], N=8), with two subjects reporting a sleep duration of only 5 to 5.5 hours. The mean body mass index was 23.2±2.2 kg/m 2 . The subjects reported a habitual alcohol intake of less than three glasses per week and a daily intake of 4.9±1.9 caffeine-containing beverages. Three subjects were smokers (subjects 1, 3 and 5). None were taking any medication in addition to insulin, other than occasional minor analgesics, except that subject 5 occasionally used tranexamic acid (Anvitoff®) for dysmenorrhea. No medication was taken during the recording period except for insulin. 
Protocol
The subjects slept during the three 2-night sessions in the completely darkened and sound-attenuated bedrooms of the sleep laboratory. The first session (P1), on treatment with PI, and the second session (H), on treatment with HI, were 4 weeks apart, and the second session (H) and the third session (P2), again on treatment with PI, were 9 weeks apart. These time intervals were chosen to ensure similar phases of the menstrual cycle in the female subjects (three subjects had cycles; see Table 1 ). The transfer from PI to HI occurred within 2 days after the first session in all except subject 2, who was transferred only after 1 week. The transfer from HI to PI occurred not later than 3 weeks after the second session, so that all subjects had been on PI at least 6 weeks before the third session. Each session consisted of 2 consecutive nights, an adaptation night followed by an experimental night. Only the latter was used for analyses if not otherwise mentioned. Due to technical problems, time in bed (TIB) in the first adaptation night (P1) varied. It was 2220 to 0545 hours for subjects 1 through 4, and 2202 to 0545 hours for subjects 5 through 8. To maintain the standardized conditions, the same TIB was used for the adaptation nights of H and P2. During all experimental nights, TIB was 2145 to 0545 hours for all subjects.
The subjects were asked to sleep from 2200 to 0600 hours 2 days before the recordings and to refrain from napping on the day of a recording. On recording days, no alcohol was permitted and caffeine was limited to one cup in the morning before 1000 hours. Compliance was assessed by determining the level of caffeine in saliva prior to sleep. Caffeine levels were analyzed by gas chromatography (VARIAN 3400, Varian Inc., Walnut Creek, Calif) / mass spectrometry (SSQ710, Finnigan Inc., San Diego, Calif) using a protocol which was modified from Garriott et al. 20 Subjective sleep quality and self-rated state were assessed 15 minutes after awakening in the morning by a questionnaire and 100-mm visual analog scales.
Diabetes control.The study participants were all on intensive insulin treatment (PI, HI) with a fast-acting insulin (Actrapid®, Novo Nordisk, Switzerland) three times before meals, and an intermediate-acting insulin (Insulatard®, Novo Nordisk, Switzerland) at bedtime. All subjects were free of hypoglycemic episodes before entering the study. Daily insulin doses were adjusted according to recommendations, aiming at fasting blood glucose of 5-7 mmol/L and random glucose of 7-10 mmol/L.
Blood glucose was measured by the subjects with their personal glucose meters before bedtime, during the night (subjects were awakened at 0145), and after awakening in the morning. The detection limit of these glucose meters was 20 mg/dl (1.1 mmol/L). If the subjects reported a blood glucose level below the detection limit, a value of 1.0 mmol/L was assigned for later analyses.
Besides the above-mentioned time points, blood glucose was assessed as usual by the subjects during the experiment, taking snacks if necessary. Due to ethical considerations it was not possible to keep subjects blinded to the type of insulin, since they had experienced HI hypoglycemic unawareness and were attentive to adverse drug reactions. Bottom panel: All-night EEG power spectrum in NREM sleep under treatment with PI compared to the treatment with HI. For each frequency bin, power density in the PI condition (mean of P1 and P2) is expressed as a percentage of the corresponding value in the HI condition (horizontal dashed line at 100%). The shaded area corresponds to ± 1 SEM. A repeated-measures ANOVA was performed for each frequency bin. The asterisk at the upper limit of the 14-Hz bin (13.25 -14.0 Hz) indicates a significant effect of the treatment (F 1,7 = 7.51, p < 0.05).
ters: a high-pass filter (-3 dB at 0.16 Hz), a low-pass filter (-3 dB at 102 Hz, -40 dB at 256 Hz), and a notch filter (50 Hz). Data were sampled with a frequency of 512 Hz, digitally filtered (EEG: low-pass FIR filter, -3 dB at 49 Hz; EMG: band-pass FIR filter -3 dB at 15.6 and 54 Hz), and stored on hard disk with a resolution of 128 Hz. Subsequently, power spectra for consecutive 4-second epochs were computed on-line by a Fast-Fourier Transform (FFT) routine. A 10% cosine window was applied. Adjacent 0.25-Hz bins were collapsed into 0.5-Hz (0.25-5.0 Hz) and 1.0-Hz (5.25-25.0 Hz) bins, and those above 25 Hz were omitted. Consecutive 20-second epochs of the C3A2 derivation were used for visual scoring of sleep stages according to standard criteria. 21 Four-second epochs with artifacts were visually identified and eliminated. Power spectra of five consecutive 4-second epochs of the C3A2 derivation were averaged and matched with the sleep scores. Mean heart rate per 20-second epochs were based on an automatic detection of consecutive RR-intervals.
Statistical analysis.Data were analyzed either according to the two treatment conditions (porcine insulin (PI) and human insulin (HI) respectively; P1 and P2 were averaged), or to the three sessions (P1, H, P2), to see order effects. Significant effects of treatment or session were assessed by analyses of variance for repeated measures (ANOVA) using the SAS® General Linear Model procedure with Greenhouse Geisser correction. In case of significant effects, contrasts were further tested either by the Wilcoxon matched-pairs signed-ranks test (subjective sleep parameters) or the paired Students t-test. Sleep latencies and EEG power density values were log-transformed, and In P2, the symbol of subject 6 is concealed by the symbol of subject 7. subjective ratings (visual analog scales) were z-transformed prior to statistical tests. RESULTS Diabetes control.The blood glucose levels determined before, during and after polysomnographic recordings were in the range of 3.2-15.0 mmol/L, with three exceptions mentioned below. On treatment with HI, the mean blood glucose levels were 8.8±1.1 (2145 hours), 8.0±1.9 (0145 hours) and 9.8±1.6 (0545 hours) (mmol/L±SEM; N=8), respectively. On treatment with usual doses of PI the respective mean values were 7.0±0.7 (2145 hours), 6.6±0.6 (0145 hours) and 7.9 ± 1.0 (0545 hours) (mmol/L±SEM). At no time did ANOVA reveal a significant difference between the glucose levels for the factor treatment (PI, HI) or session (P1, H, P2). Two subjects experienced hypoglycemia indicated by a reading of low (ie, <1.1 mmol/L) on the glucose meter with no or borderline hypoglycemic symptoms at 0145 hours: subject 3 on treatment with HI, and subject 4 on treatment with HI and PI (session P2).
Level of caffeine.The caffeine concentrations in saliva before bedtime were 2.02±0.93 [SEM] mmol/L for P1, 5.68±2.43 mmol/L for H and 4.63±1.79 mmol/L for P2. The ANOVA revealed no significant effect of treatment (PI, HI) or session (P1, H, P2).
Sleep variables derived from visual scoring.
Repeated-measures ANOVA revealed no significant effects of treatment or session for the duration of wakefulness or of any sleep stage (Table 2) . Movement time was lower during treatment with PI than during treatment with HI (F 1,7 =12.58, p<0.01), and was also lower in P2 than in either H or P1 (ANOVA: F 2,14 =7.67, p<0.01; P1-H: ns; P2-H: p<0.01; Table 2 ). All-night EEG power spectra in NREM sleep.In the absolute EEG power spectrum, activity in the 12-15 Hz range (ie, spindle frequency activity), formed a distinct peak (Fig. 1, top panel) . In the experimental nights, EEG spectral power density in NREM sleep showed a higher value in the 14-Hz bin under treatment with PI than under treatment with HI (Fig. 1) . No significant effect of the treatment was present in the delta (0.5-4.5 Hz band), theta (4.5-8 Hz band), and beta range (>15 Hz).
The distribution of NREM sleep, REM sleep and waking, and the time course of slow-wave activity (SWA, EEG power density in the 0.75 -4.5 Hz range) and of power density in the 14-Hz bin are illustrated in Fig. 2 for the three sessions of an individual subject. SWA exhibited the typical declining trend over consecutive NREM sleep episodes and the modulation by the NREM-REM sleep cycles. The 14-Hz bin in the spindle frequency range exhibited no declining trend, and the peaks tended to occur early in a NREM sleep episode. Its level was lower in the session with HI than in the two sessions with PI.
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Human vs porcine insulin: effects on sleep EEGRoth et al Figure 3 demonstrates the individual changes in the 14-Hz bin (mean of 2 nights per session) and the average over subjects. In all 8 subjects, the power was reduced from P1 to H, and in 7 of 8 subjects it was increased from H to P2. Spearmans rank correlation of the individual differences between P1 and H and between P2 and H was significant (p<0.05, r=0.71429). The differences remained significant if the 3 nights with hypoglycemic episodes were excluded.
A significant effect of session was present not only for the mean values per session but also when the experimental nights and the adaptation nights were analyzed separately (ANOVA: F 2,14 =4.08, p<0.05, N=8 and F 2,12 =10.73, p<0.007, N=7 respectively; due to technical problems the adaptation nights P1 and H were excluded for one subject). In the experimental nights P1 exceeded H (p<0.04; N=8, paired t-test), while P2 tended to be higher than H (p<0.07). The results were similar for the adaptation nights (P1-H: p<0.002; P2-H: p<0.09; N=7).
Subjective sleep quality and state in the morning. Estimated sleep latency, perceived number of awakenings, and estimated duration of wakefulness after sleep onset did not differ between treatments or sessions. No significant effects were observed in the self-ratings of sleep quality (superficial vs deep sleep) or in the state in the morning (recuperated vs tired, bad vs good mood, lack of energy vs full of energy, unable to concentrate vs fully able to concentrate). A significant effect of the factors treatment and session emerged, however, in the self-rating of relaxation (ANOVA for treatment: F 1,7 =22.43, p<0.01; for session: ECG findings.The ECG of each night was visually inspected for heart rate indicative of hypoglycemia. Heart rate varied across the night with higher values during REM sleep and waking than during NREM sleep. Other than stage-related changes, changes in heart rate that may represent signs of hypoglycemia could not be visually identified.
DISCUSSION
The study provides evidence that under near-normoglycemic conditions, porcine insulin (PI) and human insulin (HI), which differ only in one amino acid in Pos. 30 in the B chain, may have different effects on functional aspects of the human brain. The changes were seen in a specific part of the sleep EEG spectrum. Transferring patients with a long-standing diabetes mellitus from PI to HI reduced spectral power density in the 14-Hz bin in NREM sleep, an effect that was reversed after changing the treatment back to PI. The effect was robust, since all subjects exhibited a reduction in power density upon transfer from PI to HI, and all but one subject showed a rise upon restitution of PI. The effect was also significant when separately analyzing adaptation nights and experimental nights. Moreover, the magnitude of the individual changes from P1 to H and from H to P2 were correlated. The effect was specific in that no other frequency of the EEG spectrum was significantly affected.
Since a variety of factors affect spindle frequency activity (SFA, EEG power, density in the 12.0-15.0 Hz range), 17, 19, [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] it must be carefully examined whether the present effect was indeed caused by the type of insulin. The menstrual cycle is unlikely to have contributed to the changes because in the three women with menstrual cycles, the 4-and 9-week intervals between sessions ensured that the recordings were obtained at a similar phase of the cycle. 33 There was no evidence for a differential sleepdeprivation effect, as the time in bed was kept constant. The level of caffeine did not differ significantly between the sessions, and, if anything, was higher (ie, more likely to enhance SFA 19, 31 ) before the HI nights. Neither was there a significant difference in the level of blood glucose, which (with a few insignificant exceptions) was maintained in a near-normoglycemic range. EEG changes have been reported only for hypoglycemic episodes (blood glucose concentration <2.0 mmol/L) 34, 35 . Finally, drugs other than insulin which might have influenced the sleep EEG were excluded. It is therefore reasonable to conclude that the changes in SFA were effects due to the two types of insulin and not to confounding factors.
Power density in the 14-Hz bin falls into the range of sleep spindles. Spindles are a distinctive feature of the sleep EEG in NREM sleep, and their presence is seen as a peak in the EEG spectrum ( Fig.1 ; see also 22, 36) . Although sleep spindles are phasic events, their changes were shown to be faithfully represented by the EEG spectra. 26 The present results indicate therefore that spindle frequency activity (SFA) in the 14-Hz bin is more prominent during treatment with PI than during treatment with HI.
It is not unexpected that insulin-induced changes appear in the frequency band of sleep spindles, since previous studies have shown that SFA is readily affected by various physiological and pharmacological influences. During the menstrual cycle, it is the 15-Hz bin of SFA which exhibits the largest modulation (15% of the mean) with a maximum in the luteal phase. 33 Sleep deprivation causes a marked reduction of SFA in addition to enhancing slow-wave activity. 22, 26 SFA is influenced by both homeostatic and circadian factors of sleep regulation. 29, 32 The modulation of SFA by the circadian pacemaker was recently demonstrated in forced desynchrony experiments. 29 The finding that the intake of melatonin prior to a daytime nap enhanced the 14-Hz bin of SFA 29 indicated that this hormone may be involved in the circadian modulation of SFA.
Two pharmacological agents and a steroid hormone exerted distinct effects on this EEG variable. Caffeine, administered either in the morning (200 mg) 19 or in the evening (100 mg), 31 enhanced SFA in nocturnal sleep. One of the most prominent effects of various benzodiazepine hypnotics and their analogs (ie, zolpidem and zopiclone) on the sleep EEG was the enhancement of SFA in the 13-Hz bin. 17, [23] [24] [25] 27, 28 The SFA-suppressing action of the steroid pregnenolone was attributed to its partial inverse agonistic action at the benzodiazepine binding site. 27 For the interpretation of the results, the mechanisms involved in the generation of sleep spindles must be considered. The reticular nucleus of the thalamus is known to play a pacemaker role of spindle generation. Periodic bursts of action potentials with a frequency of 7 to 14 Hz are generated by this structure during sleep. [37] [38] [39] The bursts are also transferred to the cortex, where they induce excitatory postsynaptic potentials and thereby generate EEG spindles. After the onset of sleep, thalamocortical neurons are increasingly hyperpolarized. At an intermediate level of hyperpolarization, oscillations of the membrane potential in the frequency range of sleep spindles are prevalent, whereas further hyperpolarization leads to oscillations in the slow-wave range. A GABAergic signal transmission of the reticular neurons in the thalamocortical circuits may mediate the SFA-enhancement by benzodiazepines.
In a recent neurochemical theory of sleep homeostasis, adenosine was proposed to play a crucial role in sleep regulation. 40 The authors proposed that this neuromodulator mediates a sleep-need-dependent increase in potassium conductance (gK + ) in cortical and thalamic neurons, which gives rise to the typical changes in the sleep EEG. Glycogen depletion in astrocytes as a result of waking is thought to give rise to regional glucose shortage in response to an abrupt, local increase in metabolic demand, which, consequently, results in an increased extracellular concentration of adenosine. In the framework of this theory, we interpreted the delayed slow-wave suppressing and SFA-enhancing action of caffeine as being possibly due to the blockade of adenosine receptors during waking. 19 According to the theory of Benington and Heller, the replenishment of astrocytic glycogen can occur only during NREM sleep. Glycogen in glial cells may provide fuel molecules for neighboring neurons. 41 Insulin has been reported to stimulate glucose uptake in rat brain glia cells 42 and human glioblastoma cells, 43 and to enhance glycogen accumulation in astrogliarich primary cultures from neonatal rat brain. 44 Therefore, if the glycogen content of astrocytes is involved in sleep regulation, insulin in the brain may have a modulatory influence. Although porcine and human insulin do not differ in terms of their binding characteristics to insulin receptor isoforms in human brain, 45 differences in the entry into the brain or the degradation in the brain may account for the different neurophysiological responses. 13, 14 If the cerebral steady-state concentration of PI and HI are indeed not the same, a differential action on the thalamocortical system would be conceivable in the framework of the Benington-Heller theory, an interpretation that would account for the differences in SFA in the sleep EEG.
In contrast to the prominent changes in the sleep EEG, there were no significant treatment effects on sleep variables, with the exception of movement time (which was lower under PI treatment). Since neither the duration of waking nor sleep latency was different, and since the change from P1 to H was small, we do not believe that the difference in movement time reflects a differential effect of the two types of insulin on sleep regulation. The observation of Flanigan et al 15 reported in an abstractthat sleep latency was shorter during HI treatment than during PI treatment, was not confirmed in the present experiments. The subjects rated themselves in the morning as more relaxed and their sleep as more sound in the PI sessions than in the HI session. The interpretation of this finding is difficult since the subjects were not blinded to their treatment and may have been more apprehensive in the HI conditions. They are, however, consistent with the observations made in larger diabetic groups reporting decreased well-being and less safety feeling with transfer from the traditional animal insulin to HI without medical indication. 46 Due to ethical considerations, the experiment was not designed with a double-blind schedule. It has been reported that a single hypoglycemia episode can trigger the loss of warning mechanisms of hypoglycemic events. 47 Since all subjects had experienced HI hypoglycemia unawareness in the past and had the opportunity to express an opinion about not being blinded, it would have been unethical to expose them to this risk during 4 weeks of HI treatment.
In conclusion, the present experiments demonstrate that PI and HI have differential effects on the 14-Hz spindle frequency component of the sleep EEG and therefore have different effects on specific functional aspects of the brain. While it has been previously reported that the sensory event-related potentials differed during the initial phase of PI-or HI-induced hypoglycemia, 13, 14 the changes of the sleep EEG described in the present paper were observed under near-normoglycemic conditions, and were not contingent on insulin administration but represented long-term effects. It is not unreasonable to conclude that other brain functions could be differentially affected by the two types of insulin.
